{"lastClose": 5.699999809265137, "len": 1110, "date": "2023-03-10", "alpha_1": -0.2847508958770416, "beta_1": 1.6484361483845458, "drawup_1": 1.5486725887776869, "natr_1": 15.004617202427545, "sup_1": -0.2555555574145701, "res_1": 0.4432748920577274, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE"], "rsi_1": 28.835485858381983, "adx_1": 26.38419476900644, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.1892563920424074, "stratHoldAlpha_1": 250.86830369167828, "stratHoldDrawdown_1": -0.6389819353139861, "alpha_3mo": -0.029300933241898197, "beta_3mo": 2.094388415069765, "drawup_3mo": 0.4608541290620036, "natr_3mo": 15.004617202427545, "sup_3mo": -0.03859642782589754, "res_3mo": 0.2175438825443518, "bullPattern_3mo": ["HAMMER"], "bearPattern_3mo": ["3OUTSIDE"], "rsi_3mo": 14.622639599708679, "adx_3mo": 23.351937519595086, "drawdown_3mo": -0.30572475240187114, "stratHoldSharpe_3mo": -1.8417625573964016, "stratHoldAlpha_3mo": 249.89474601309416, "stratHoldDrawdown_3mo": -0.27582419904894573, "Name": "Allogene Therapeutics Inc.", "Market Cap": 812624218, "IPO Year": 2018.0, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Sector": "Health Care", "alpha%_1": 0.22070464698256775, "beta%_1": 0.9067239696875359, "drawup%_1": 0.9973599072198164, "natr%_1": 0.9999948568845842, "drawdown%_1": 0.05986135847832339, "stratHoldSharpe%_1": 0.3872754579327086, "stratHoldAlpha%_1": 0.29611020186551906, "stratHoldDrawdown%_1": 0.046498577762225095, "alpha%_3mo": 0.2798485806228569, "beta%_3mo": 0.9702787070894066, "drawup%_3mo": 0.8990717735529555, "natr%_3mo": 0.9999933103230293, "drawdown%_3mo": 0.05697595336573522, "stratHoldSharpe%_3mo": 0.14545989465846532, "stratHoldAlpha%_3mo": 0.021142850570977964, "stratHoldDrawdown%_3mo": 0.06234584778603568}